(OMEX) Odyssey Marine Exploration - Overview
Stock: Polymetallic Nodules, Subsea Phosphates, Marine Services
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 203% |
| Relative Tail Risk | -21.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.38 |
| Alpha | 194.76 |
| Character TTM | |
|---|---|
| Beta | 1.803 |
| Beta Downside | 0.696 |
| Drawdowns 3y | |
|---|---|
| Max DD | 94.60% |
| CAGR/Max DD | -0.20 |
Description: OMEX Odyssey Marine Exploration December 22, 2025
Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) focuses on discovering, validating, and developing seafloor mineral resources, notably polymetallic nodules that supply battery-grade nickel, copper, cobalt and manganese, as well as subsea phosphate deposits used in fertilizer production. The firm also conducts exploration for gold and offers a suite of marine-operations, regulatory-compliance, and research services to governments, rights holders, and industry partners worldwide, operating from its Tampa, Florida headquarters.
Key sector drivers include the accelerating demand for battery metals-projected to grow at a CAGR of ~12% through 2030-and the tightening global supply of phosphate, which underpins agricultural fertilizer markets. In FY 2023, OMEX reported a cash burn of roughly $15 million while maintaining a modest cash runway of $30 million, reflecting the capital-intensive nature of deep-sea exploration. The company’s progress is also tied to regulatory milestones with the International Seabed Authority, which governs licensing for seabed mining and can materially affect project timelines.
For a deeper quantitative view, ValueRay’s platform provides granular financial and operational metrics that can help you model OMEX’s upside.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: -30.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.45 > 0.02 and ΔFCF/TA -45.21 > 1.0 |
| NWC/Revenue: -2185 % < 20% (prev -3470 %; Δ 1285 % < -1%) |
| CFO/TA -0.45 > 3% & CFO -7.92m > Net Income -30.7m |
| Net Debt (6.05m) to EBITDA (1.32b): 0.00 < 3 |
| Current Ratio: 0.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (30.8m) vs 12m ago 21.93% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 2.37% > 50% (prev 3.67%; Δ -1.31% > 0%) |
| Interest Coverage Ratio: 0.97 > 6 (EBITDA TTM 1.32b / Interest Expense TTM 1.35b) |
Altman Z'' 10.00
| A: -0.58 (Total Current Assets 6.20m - Total Current Liabilities 16.4m) / Total Assets 17.7m |
| B: -17.26 (Retained Earnings -306.1m / Total Assets 17.7m) |
| C: 66.65 (EBIT TTM 1.32b / Avg Total Assets 19.7m) |
| D: -3.03 (Book Value of Equity -306.1m / Total Liabilities 101.0m) |
| Altman-Z'' Score: 384.7 = AAA |
Beneish M -4.00
| DSRI: 1.71 (Receivables 67.3k/67.3k, Revenue 467.1k/799.1k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.75 (AQ_t 0.62 / AQ_t-1 0.83) |
| SGI: 0.58 (Revenue 467.1k / 799.1k) |
| TATA: -1.28 (NI -30.7m - CFO -7.92m) / TA 17.7m) |
| Beneish M-Score: -4.21 (Cap -4..+1) = AAA |
What is the price of OMEX shares?
Over the past week, the price has changed by -13.76%, over one month by -27.88%, over three months by -15.10% and over the past year by +239.58%.
Is OMEX a buy, sell or hold?
What are the forecasts/targets for the OMEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.5 | 360.1% |
| Analysts Target Price | 7.5 | 360.1% |
| ValueRay Target Price | 1.6 | -3.1% |
OMEX Fundamental Data Overview February 02, 2026
Revenue TTM = 467.1k USD
EBIT TTM = 1.32b USD
EBITDA TTM = 1.32b USD
Long Term Debt = 3.90m USD (from longTermDebt, last quarter)
Short Term Debt = 6.49m USD (from shortTermDebt, last quarter)
Debt = 11.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.05m USD (from netDebt column, last quarter)
Enterprise Value = 111.4m USD (105.3m + Debt 11.9m - CCE 5.82m)
Interest Coverage Ratio = 0.97 (Ebit TTM 1.32b / Interest Expense TTM 1.35b)
EV/FCF = -14.07x (Enterprise Value 111.4m / FCF TTM -7.92m)
FCF Yield = -7.11% (FCF TTM -7.92m / Enterprise Value 111.4m)
FCF Margin = -1695 % (FCF TTM -7.92m / Revenue TTM 467.1k)
Net Margin = -6568 % (Net Income TTM -30.7m / Revenue TTM 467.1k)
Gross Margin = unknown ((Revenue TTM 467.1k - Cost of Revenue TTM 1.93m) / Revenue TTM)
Tobins Q-Ratio = 6.28 (Enterprise Value 111.4m / Total Assets 17.7m)
Interest Expense / Debt = 11.4k% (Interest Expense 1.35b / Debt 11.9m)
Taxrate = 0.0% (0.0 / 6.25m)
NOPAT = 1.32b (EBIT 1.32b * (1 - 0.00%))
Current Ratio = 0.38 (Total Current Assets 6.20m / Total Current Liabilities 16.4m)
Debt / Equity = -0.26 (negative equity) (Debt 11.9m / totalStockholderEquity, last quarter -45.4m)
Debt / EBITDA = 0.00 (Net Debt 6.05m / EBITDA 1.32b)
Debt / FCF = -0.76 (negative FCF - burning cash) (Net Debt 6.05m / FCF TTM -7.92m)
Total Stockholder Equity = -32.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -155.4% (out of range, set to none)
RoE = 95.57% (negative equity) (Net Income TTM -30.7m / Total Stockholder Equity -32.1m)
RoCE = -4668 % (out of range, set to none) (EBIT 1.32b / Capital Employed (Equity -32.1m + L.T.Debt 3.90m))
RoIC = 19.7k% (out of range, set to none) (NOPAT 1.32b / Invested Capital 6.69m)
WACC = 11.29% (E(105.3m)/V(117.2m) * Re(12.56%) + (debt cost/tax rate unavailable))
Discount Rate = 12.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 22.71%
Fair Price DCF = unknown (Cash Flow -7.92m)
EPS Correlation: -1.38 | EPS CAGR: -18.48% | SUE: -1.56 | # QB: 0
Revenue Correlation: -83.19 | Revenue CAGR: -31.37% | SUE: 1.39 | # QB: 1